David A. Siegel Biofrontera Inc. Transaction History

Two Sigma Advisers, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$37.2 - $99.2 $736,560 - $1.96 Million	-19,800 Reduced 55.0%	16,200 $30,000
Q1 2022 May 16, 2022	BUY	$45.0 - $138.4 $783,000 - $2.41 Million	17,400 Added 93.55%	36,000 $120,000
Q4 2021 Feb 14, 2022	BUY	$49.4 - $263.4 $918,840 - $4.9 Million	18,600 New	18,600 $140,000

Ticker BFRI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 23,551,000
Market Cap $23.8M
Description
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for phot...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.